⌘K
Phychem Technologies is an SME engaged in manufacturing rotational molding (roto molding) compounds and distributing various products and chemicals used in the rotomolding industry. The company boasts a wide range of products and long-standing relationships with diversified customers across geographies.
The post-IPO valuation appears attractive, especially the P/E multiple. Market sentiment, while showing a weak GMP, is counterbalanced by strong subscription figures across all investor categories and the participation of anchor investors. While there are notable risks, particularly concerning undisclosed litigation details and geographical concentration, the overall financial strength and attractive valuation outweigh these concerns for a long-term perspective. The lack of detailed DRHP information is largely mitigated by comprehensive external data.
Despite strong subscription and fundamentals, the weak GMP suggests limited listing pop. However, strong institutional demand (QIB, NII) and anchor participation provide some confidence for moderate gains.
The company's strong financial performance and attractive valuation could attract short-term investors post-listing, but the declining GMP trend and lack of detailed future outlook might cap immediate upside.
Excellent return ratios, consistent profit growth, and a low debt profile make it an attractive long-term investment, assuming the company can mitigate operational and litigation risks and sustain its growth trajectory.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB | 12,72,000 | 47.11% | |
| NII (HNI) | 3,90,000 | 14.44% | |
| Retail | 9,00,000 | 33.33% | |
| Market Maker | 1,38,000 | 5.11% |
| Investor | |||
|---|---|---|---|
| INNOVATIVE VISION FUND | 2,04,000 | ₹1.1 Cr | 26.77% |
| LRSD SECURITIES PVT.LTD. | 1,86,000 | ₹1 Cr | 24.41% |
| SB OPPORTUNITIES FUND II | 1,86,000 | ₹1 Cr | 24.41% |
| TATTVAM AIF TRUST | 1,86,000 | ₹1 Cr | 24.41% |
Premium gain of 1.85% over issue price.
Strong and consistent growth in PAT and EBITDA.
Excellent return ratios (ROE, ROCE, RoNW).
Low debt-to-equity ratio.
Attractive post-IPO P/E valuation.
High promoter holding post-IPO.
Diversified customer base and long-standing relationships.
Strong subscription across all categories (QIB, NII, Retail).
Presence of quality anchor investors.
Successful expansion into new geographies or product lines, favorable industry growth for rotomolding, effective management of raw material costs.
Continued organic growth from existing customer relationships, stable demand in the rotomolding industry, moderate improvements in operational efficiency.
Intensified competition, adverse regulatory changes, significant fluctuations in raw material prices or foreign exchange rates, negative outcomes from litigations.
Positive: Strong PAT and EBITDA CAGR (49.2% and 48.0% respectively).
Concern: Weak and declining GMP (1.85% gain).
Advisory: litigation disclosed (advisory, not a specific severe matter)
Listing-gain vs long-term: Neutral / Apply.